Donahoe PK - Search Results

1

Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.

Parry RL, Chin TW, Epstein J, Hudson PL, Powell DM, Donahoe PK. Parry RL, et al. Among authors: donahoe pk. Cancer Res. 1992 Mar 1;52(5):1182-6. Cancer Res. 1992. PMID: 1531323

2

Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for müllerian inhibiting substance.

Lee MM, Cate RL, Donahoe PK, Waneck GL. Lee MM, et al. Among authors: donahoe pk. Endocrinology. 1992 Feb;130(2):847-53. doi: 10.1210/endo.130.2.1346380. Endocrinology. 1992. PMID: 1346380

3

Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects.

Ragin RC, Donahoe PK, Kenneally MK, Ahmad MF, MacLaughlin DT. Ragin RC, et al. Among authors: donahoe pk. Protein Expr Purif. 1992 Jun;3(3):236-45. doi: 10.1016/1046-5928(92)90020-w. Protein Expr Purif. 1992. PMID: 1392620

4

Identification of müllerian inhibiting substance specific binding in human cell lines.

MacLaughlin DT, Levin RK, Catlin EA, Taylor LA, Preffer FI, Donahoe PK. MacLaughlin DT, et al. Among authors: donahoe pk. Horm Metab Res. 1992 Dec;24(12):570-5. doi: 10.1055/s-2007-1003392. Horm Metab Res. 1992. PMID: 1478615

5

Mullerian inhibiting substance binding and uptake.

Catlin EA, Ezzell RM, Donahoe PK, Manganaro TF, Ebb RG, MacLaughlin DT. Catlin EA, et al. Among authors: donahoe pk. Dev Dyn. 1992 Apr;193(4):295-9. doi: 10.1002/aja.1001930402. Dev Dyn. 1992. PMID: 1511169 Free article.

6

The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells.

Kim JH, Seibel MM, MacLaughlin DT, Donahoe PK, Ransil BJ, Hametz PA, Richards CJ. Kim JH, et al. Among authors: donahoe pk. J Clin Endocrinol Metab. 1992 Sep;75(3):911-7. doi: 10.1210/jcem.75.3.1517385. J Clin Endocrinol Metab. 1992. PMID: 1517385

7

Isolation of the rat gene for Mullerian inhibiting substance.

Haqq C, Lee MM, Tizard R, Wysk M, DeMarinis J, Donahoe PK, Cate RL. Haqq C, et al. Among authors: donahoe pk. Genomics. 1992 Apr;12(4):665-9. doi: 10.1016/0888-7543(92)90291-y. Genomics. 1992. PMID: 1572639

8

Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.

MacLaughlin DT, Hudson PL, Graciano AL, Kenneally MK, Ragin RC, Manganaro TF, Donahoe PK. MacLaughlin DT, et al. Among authors: donahoe pk. Endocrinology. 1992 Jul;131(1):291-6. doi: 10.1210/endo.131.1.1612008. Endocrinology. 1992. PMID: 1612008

9

Müllerian inhibiting substance in reproduction and cancer.

Donahoe PK. Donahoe PK. Mol Reprod Dev. 1992 Jun;32(2):168-72. doi: 10.1002/mrd.1080320213. Mol Reprod Dev. 1992. PMID: 1637555 Review.

10

Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.

Hirobe S, He WW, Lee MM, Donahoe PK. Hirobe S, et al. Among authors: donahoe pk. Endocrinology. 1992 Aug;131(2):854-62. doi: 10.1210/endo.131.2.1639028. Endocrinology. 1992. PMID: 1639028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters